Japanese Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Hisamitsu Pharmaceutical

Market Cap: JP¥301.0b

Manufactures and sells pharmaceuticals in Japan.

Chordia Therapeutics

Market Cap: JP¥14.9b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Veritas In Silico

Market Cap: JP¥4.0b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

Towa Pharmaceutical

Market Cap: JP¥145.4b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

Noile-Immune Biotech

Market Cap: JP¥7.8b

Researches and develops CAR-T cells for cancer immunotherapies.

Ono Pharmaceutical

Market Cap: JP¥730.5b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

FunPep

Market Cap: JP¥4.2b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

PRISM BioLabLTD

Market Cap: JP¥8.6b

A biotechnology company, discovers and develops small molecule inhibitors of protein-protein interaction targets utilizing proprietary PepMetics technology for treating patients suffering from cancer, autoimmune, fibrosis, and other diseases.

Precision System Science

Market Cap: JP¥5.5b

Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.

AnGes

Market Cap: JP¥21.3b

Engages in the research and development of gene-based medical products.

Santen Pharmaceutical

Market Cap: JP¥576.9b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

GNI Group

Market Cap: JP¥189.1b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Transgenic Group

Market Cap: JP¥2.9b

Develops, distributes, and licenses genetically modified animals and antibodies in Japan.

MEDINET

Market Cap: JP¥8.7b

Operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan.

Healios K.K

Market Cap: JP¥45.8b

Engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

WDB coco

Market Cap: JP¥7.1b

Provides contract services to pharmaceutical companies in Japan.

ReproCELL

Market Cap: JP¥16.9b

Provides stem cell research and drug discovery services in Japan.

CellSeed

Market Cap: JP¥17.0b

Develops cell sheet regenerative medicines.

Chiome Bioscience

Market Cap: JP¥10.4b

Engages in the research and development of drug discovery technology platforms worldwide.

Seikagaku

Market Cap: JP¥33.7b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

Immuno-Biological Laboratories

Market Cap: JP¥4.6b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

Cyfuse Biomedical K.K

Market Cap: JP¥7.2b

Engages in the development, manufacture, and sale of regenerative medicine products in Japan.

Tsubota Laboratory

Market Cap: JP¥10.0b

Engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.

KYORIN Pharmaceutical

Market Cap: JP¥84.2b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

PeptiDream

Market Cap: JP¥210.9b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Delta-Fly Pharma

Market Cap: JP¥6.1b

Develops anticancer drugs.

MedRx

Market Cap: JP¥3.1b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Wakamoto PharmaceuticalLtd

Market Cap: JP¥10.4b

Manufactures and sells ethical and non-prescription drugs in Japan.

Oncolys BioPharma

Market Cap: JP¥15.2b

Engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States.

Fuji Pharma

Market Cap: JP¥32.5b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

SanBio

Market Cap: JP¥197.4b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

3-D Matrix

Market Cap: JP¥28.2b

Develops self-assembling peptide technology in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥68.2b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Modalis Therapeutics

Market Cap: JP¥6.5b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

StemRIM

Market Cap: JP¥20.3b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.